INSTIL BIO INC (TIL) Stock Income Statement
NASDAQ:TIL - Nasdaq - US45783C2008 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 140.00K | |||
| Operating Expenses | 50.85M | 87.16M | 203.29M | 155.56M | 33.78M | |||
| Research and Development | 9.95M | 39.60M | 141.06M | 107.25M | 19.40M | |||
| Selling, General, and Administrative Expenses | 40.90M | 47.55M | 62.24M | 48.31M | 14.38M | |||
| Operating Income | -50.85M | -87.16M | -203.29M | -155.56M | -33.64M | |||
| Interest Income/Expense | -2.01M | 3.66M | 1.77M | -1.20M | -3.69M | |||
| Other Income/Expense | 4.12M | -575.00K | -560.00K | N/A | -260.00K | |||
| Non Recurring Items | -29.30M | -72.01M | -23.17M | N/A | N/A | |||
| Income Before Taxes | -78.03M | -156.09M | -225.25M | -156.76M | -37.59M | |||
| Income Tax | N/A | 0.00 | -2.07M | 40.00K | 150.00K | |||
| Net Income | -78.03M | -156.09M | -223.18M | -156.79M | -37.74M | |||
| EBITDA | -47.73M | -82.40M | -197.30M | -152.81M | -33.38M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -11.97 | -24.00 | -1.72 | -1.48 | -0.30 | |||
| Non GAAP EPS | -11.97 | -23.99 | -6.11 | -1.69 | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | -26957.14% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -24028.57% | |||
All data in USD